Description
An inhibitor of DDHD2 (IC50 = 1.3 nM); selective for DDHD2 over greater than 50 serine hydrolases, including DDHD1 and Sec23ip, but does inhibit ABHD6; inhibits DDHD2 and ABHD6 in Neuro2A cells at 95% at 25 nM; prevents increases in TAG hydrolase activity in HEK293T cell lysates expressing DDHD2 and incubated with a radiolabeled TAG substrate at 2 µM; decreases TAG levels in mouse CNS at 20 mg/kg twice per day for four days; reverses DDHD2-induced lipid droplet reduction in COS-7 cells expressing species recombinant DDHD2 and loaded with oleic acid at 2 µM
Formal name: N-cyclohexyl-N-(2-phenylethyl)-4-[4-(trifluoromethoxy)phenyl]-2H-1,2,3-triazole-2-carboxamide
Synonyms:
Molecular weight: 458.5
CAS: 1632236-44-2
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Small Molecule Inhibitors|Glycerolipid Lipases||Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Lipid Biochemistry|Glycerolipids||Research Area|Lipid Biochemistry|Glycerophospholipids|Phospholipases||Research Area|Neuroscience